Synthetic Peptides for Study of Human Immunodeficiency Virus Infection

Author： Dettin M.   Scarinci C.   Pasquato A.   Di Bello C.  

Publisher： Humana Press, Inc

ISSN： 0273-2289

Source： Applied Biochemistry and Biotechnology, Vol.102, Iss.1-3, 2002-07, pp. : 41-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic Peptides in the Diagnosis of HIV Infection

By  

Current Protein and Peptide Science, Vol. 4, Iss. 4, 2003-08 ,pp. : 285-290

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides

By Ling H.   Zhang X-Y.   Usami O.   Hattori T.  

Biochemical and Biophysical Research Communications, Vol. 297, Iss. 3, 2002-09 ,pp. : 625-631

Elsevier

Access to resources Recommend Favorite

GB Virus C (GBV-C) / Hepatitis G Virus (HGV): Towards the Design of Synthetic Peptides-based Biosensors for Immunodiagnosis of GBV-C / HGV Infection

By  

Current Protein and Peptide Science, Vol. 4, Iss. 4, 2003-01 ,pp. : 291-298

Bentham Science Publishers

Access to resources Recommend Favorite

RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

By Subramanya Sandesh   Kim Sang-Soo   Manjunath N   Shankar Premlata  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 201-213

Informa Healthcare

Access to resources Recommend Favorite

Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers

By Wei X.   Götte M.   Wainberg M.A.  

Nucleic Acids Research, Vol. 28, Iss. 16, 2000-08 ,pp. : 3065-3074

Oxford University Press

Access to resources Recommend Favorite